Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept.


BACKGROUND Etanercept (ETN) 50 mg once weekly (QW) or 50 mg twice weekly (BIW) for 12 weeks, followed by 50 mg QW in all subjects to Week 24 improved psoriasis in patients with concomitant psoriatic arthritis in the PRESTA trial. OBJECTIVES To use data from PRESTA to evaluate the effect of ETN in the treatment of psoriasis by Psoriasis Area Severity Index… (More)
DOI: 10.1111/bjd.13139


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.